Actively Recruiting
Led by Centre Hospitalier Universitaire, Amiens · Updated on 2025-06-12
302
Participants Needed
1
Research Sites
21 weeks
Total Duration
C
Centre Hospitalier Universitaire, Amiens
Lead Sponsor
C
Clinique Victor Pauchet
Collaborating Sponsor
Postoperative atrial fibrillation (POAF) affects about 20% of patients after thoracic surgery and can lead to serious complications like heart failure, stroke, and increased risk of death. Researchers are studying how well smartwatches with single-lead ECG and detection algorithms can identify POAF compared to standard care. The goal is to find early diagnosis methods to improve patient outcomes after surgery. Participants are randomly assigned to one of two groups: the smartwatch group, where they use a smartwatch for rhythm monitoring, or the control group, which receives standard care without smartwatch monitoring. If POAF episodes are detected, they are confirmed with a 12-lead ECG. The study evaluates the incidence of POAF at day 7 and other outcomes such as cardiovascular prognosis and AF management up to 6 months. During the study, participants will be monitored for heart rhythm using the smartwatch or standard methods. Researchers will assess how often POAF occurs by day 7, the rate of asymptomatic POAF, and cardiovascular health at day 3 and 6 months. They will also evaluate the feasibility of smartwatch monitoring and track recurrence and management of AF at 3 and 6 months. The study starts in June 2025 and continues until December 2027.
CONDITIONS
Diagnosis of Atrial Fibrillation in Postoperative Thoracic Surgery Using a Smartwatch
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 7 days
Participants in the smartwatch group undergo rhythm monitoring using a smartwatch after thoracic surgery, while the control group receives standard care without smartwatch monitoring.
Daily monitoring visits or assessments for 7 days
Duration - Up to 6 months
Participants are followed up to assess cardiovascular prognosis and recurrence or management of atrial fibrillation after surgery.
Visits at 3 months and 6 months post-surgery
Total: 1 location
1
Centre hospitalier Amiens
Amiens, France, 80054
Actively Recruiting
P
Pierre Huette, MD
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Pierre Huette, Christophe Beyls, Momar Diouf...
https://pubmed.ncbi.nlm.nih.gov/40204329